» Articles » PMID: 27912097

LncPRESS1 Is a P53-Regulated LncRNA That Safeguards Pluripotency by Disrupting SIRT6-Mediated De-acetylation of Histone H3K56

Overview
Journal Mol Cell
Publisher Cell Press
Specialty Cell Biology
Date 2016 Dec 3
PMID 27912097
Citations 128
Authors
Affiliations
Soon will be listed here.
Abstract

Recent evidence suggests that lncRNAs play an integral regulatory role in numerous functions, including determination of cellular identity. We determined global expression (RNA-seq) and genome-wide profiles (ChIP-seq) of histone post-translational modifications and p53 binding in human embryonic stem cells (hESCs) undergoing differentiation to define a high-confidence set of 40 lncRNAs, which are p53 transcriptional targets. We focused on lncRNAs highly expressed in pluripotent hESCs and repressed by p53 during differentiation to identify lncPRESS1 as a p53-regulated transcript that maintains hESC pluripotency in concert with core pluripotency factors. RNA-seq of hESCs depleted of lncPRESS1 revealed that lncPRESS1 controls a gene network that promotes pluripotency. Further, we found that lncPRESS1 physically interacts with SIRT6 and prevents SIRT6 chromatin localization, which maintains high levels of histone H3K56 and H3K9 acetylation at promoters of pluripotency genes. In summary, we describe a p53-regulated, pluripotency-specific lncRNA that safeguards the hESC state by disrupting SIRT6 activity.

Citing Articles

Non-Coding RNAs in Cancer: Structure, Function, and Clinical Application.

Marton E, Varga A, Domoszlai D, Buglyo G, Balazs A, Penyige A Cancers (Basel). 2025; 17(4).

PMID: 40002172 PMC: 11853212. DOI: 10.3390/cancers17040579.


Investigating the role of exosomal long non-coding RNAs in drug resistance within female reproductive system cancers.

Shirani N, Abdi N, Chehelgerdi M, Yaghoobi H, Chehelgerdi M Front Cell Dev Biol. 2025; 13:1485422.

PMID: 39925739 PMC: 11802832. DOI: 10.3389/fcell.2025.1485422.


Gain-of-Function Chromatin Remodeling Activity of Oncogenic FOXL2C134W Reprograms Glucocorticoid Receptor Occupancy to Drive Granulosa Cell Tumors.

Welte T, Vuttaradhi V, Khlebus E, Brodsky A, Flores Legarreta A, Celestino J Cancer Res. 2024; 85(5):875-893.

PMID: 39652611 PMC: 11873728. DOI: 10.1158/0008-5472.CAN-24-2341.


Deciphering the role of LOC124905135-related non-coding RNA cluster in human cancers: A comprehensive review.

Eftekhari Kenzerki M, Mohajeri Khorasani A, Zare I, Amirmahani F, Ghasemi Y, Hamblin M Heliyon. 2024; 10(22):e39931.

PMID: 39641053 PMC: 11617737. DOI: 10.1016/j.heliyon.2024.e39931.


Interplay between epigenetics, senescence and cellular redox metabolism in cancer and its therapeutic implications.

Balamurli G, Liew A, Tee W, Pervaiz S Redox Biol. 2024; 78:103441.

PMID: 39612910 PMC: 11629570. DOI: 10.1016/j.redox.2024.103441.


References
1.
Akdemir K, Jain A, Allton K, Aronow B, Xu X, Cooney A . Genome-wide profiling reveals stimulus-specific functions of p53 during differentiation and DNA damage of human embryonic stem cells. Nucleic Acids Res. 2013; 42(1):205-23. PMC: 3874181. DOI: 10.1093/nar/gkt866. View

2.
Sun S, Del Rosario B, Szanto A, Ogawa Y, Jeon Y, Lee J . Jpx RNA activates Xist by evicting CTCF. Cell. 2013; 153(7):1537-51. PMC: 3777401. DOI: 10.1016/j.cell.2013.05.028. View

3.
Rinn J . lncRNAs: linking RNA to chromatin. Cold Spring Harb Perspect Biol. 2014; 6(8). PMC: 4107985. DOI: 10.1101/cshperspect.a018614. View

4.
Michishita E, McCord R, Boxer L, Barber M, Hong T, Gozani O . Cell cycle-dependent deacetylation of telomeric histone H3 lysine K56 by human SIRT6. Cell Cycle. 2009; 8(16):2664-6. PMC: 4474138. DOI: 10.4161/cc.8.16.9367. View

5.
Tan Y, Xue Y, Song C, Grunstein M . Acetylated histone H3K56 interacts with Oct4 to promote mouse embryonic stem cell pluripotency. Proc Natl Acad Sci U S A. 2013; 110(28):11493-8. PMC: 3710873. DOI: 10.1073/pnas.1309914110. View